Annual CFO
-$146.85 M
-$36.98 M-33.66%
31 December 2023
Summary:
Day One Biopharmaceuticals annual cash flow from operations is currently -$146.85 million, with the most recent change of -$36.98 million (-33.66%) on 31 December 2023. During the last 3 years, it has fallen by -$133.36 million (-988.69%). DAWN annual CFO is now -3152.56% below its all-time high of -$4.51 million, reached on 31 December 2019.DAWN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$50.75 M
+$99.88 M+203.31%
30 September 2024
Summary:
Day One Biopharmaceuticals quarterly cash flow from operations is currently $50.75 million, with the most recent change of +$99.88 million (+203.31%) on 30 September 2024. Over the past year, it has increased by +$87.82 million (+236.93%). DAWN quarterly CFO is now at all-time high.DAWN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$89.48 M
+$87.82 M+49.53%
30 September 2024
Summary:
Day One Biopharmaceuticals TTM cash flow from operations is currently -$89.48 million, with the most recent change of +$87.82 million (+49.53%) on 30 September 2024. Over the past year, it has increased by +$51.31 million (+36.45%). DAWN TTM CFO is now -4191.46% below its all-time high of -$2.08 million, reached on 31 March 2020.DAWN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DAWN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.7% | +236.9% | +36.5% |
| 3 y3 years | -988.7% | +515.3% | -116.6% |
| 5 y5 years | - | - | - |
DAWN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -988.7% | at low | at high | +202.1% | -116.6% | +49.5% |
| 5 y | 5 years | -3152.6% | at low | at high | +202.1% | -4191.5% | +49.5% |
| alltime | all time | -3152.6% | at low | at high | +202.1% | -4191.5% | +49.5% |
Day One Biopharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $50.75 M(-203.3%) | -$89.48 M(-49.5%) |
| June 2024 | - | -$49.13 M(-1.2%) | -$177.29 M(+3.9%) |
| Mar 2024 | - | -$49.73 M(+20.2%) | -$170.60 M(+16.2%) |
| Dec 2023 | -$146.85 M(+33.7%) | -$41.37 M(+11.6%) | -$146.85 M(+4.3%) |
| Sept 2023 | - | -$37.06 M(-12.7%) | -$140.79 M(+10.9%) |
| June 2023 | - | -$42.43 M(+63.3%) | -$126.94 M(+11.1%) |
| Mar 2023 | - | -$25.98 M(-26.4%) | -$114.30 M(+4.0%) |
| Dec 2022 | -$109.87 M | -$35.31 M(+52.1%) | -$109.87 M(+25.2%) |
| Sept 2022 | - | -$23.21 M(-22.1%) | -$87.73 M(+14.3%) |
| June 2022 | - | -$29.79 M(+38.1%) | -$76.74 M(+27.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$21.56 M(+63.7%) | -$60.36 M(+24.4%) |
| Dec 2021 | -$48.54 M(+259.8%) | -$13.17 M(+7.8%) | -$48.54 M(+17.5%) |
| Sept 2021 | - | -$12.22 M(-8.8%) | -$41.31 M(+26.5%) |
| June 2021 | - | -$13.41 M(+37.6%) | -$32.66 M(+54.5%) |
| Mar 2021 | - | -$9.74 M(+64.1%) | -$21.15 M(+56.8%) |
| Dec 2020 | -$13.49 M(+198.8%) | -$5.94 M(+66.0%) | -$13.49 M(+78.6%) |
| Sept 2020 | - | -$3.58 M(+89.5%) | -$7.55 M(+90.1%) |
| June 2020 | - | -$1.89 M(-9.4%) | -$3.97 M(+90.6%) |
| Mar 2020 | - | -$2.08 M | -$2.08 M |
| Dec 2019 | -$4.51 M | - | - |
FAQ
- What is Day One Biopharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual CFO year-on-year change?
- What is Day One Biopharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly CFO year-on-year change?
- What is Day One Biopharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals TTM CFO year-on-year change?
What is Day One Biopharmaceuticals annual cash flow from operations?
The current annual CFO of DAWN is -$146.85 M
What is the all time high annual CFO for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual cash flow from operations is -$4.51 M
What is Day One Biopharmaceuticals annual CFO year-on-year change?
Over the past year, DAWN annual cash flow from operations has changed by -$36.98 M (-33.66%)
What is Day One Biopharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of DAWN is $50.75 M
What is the all time high quarterly CFO for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly cash flow from operations is $50.75 M
What is Day One Biopharmaceuticals quarterly CFO year-on-year change?
Over the past year, DAWN quarterly cash flow from operations has changed by +$87.82 M (+236.93%)
What is Day One Biopharmaceuticals TTM cash flow from operations?
The current TTM CFO of DAWN is -$89.48 M
What is the all time high TTM CFO for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high TTM cash flow from operations is -$2.08 M
What is Day One Biopharmaceuticals TTM CFO year-on-year change?
Over the past year, DAWN TTM cash flow from operations has changed by +$51.31 M (+36.45%)